👉 Hepatitis engineering refers to the innovative field of genetic modification aimed at developing novel strategies to combat hepatitis, a group of viral infections primarily caused by hepatitis B and C viruses. This approach involves engineering viruses or host cells to enhance antiviral immunity, reduce viral replication, or even eradicate the virus from infected individuals. For hepatitis B, researchers have engineered viruses to express therapeutic genes that boost the host's immune response or directly inhibit viral replication. In the case of hepatitis C, efforts focus on modifying host cells to resist viral infection or engineering immune cells to more effectively target and destroy infected hepatocytes. Additionally, synthetic biology techniques are being explored to create artificial antiviral agents or to develop new vaccines that can induce robust and long-lasting immunity. Hepatitis engineering holds significant promise for transforming current treatment paradigms and potentially leading to cures for these chronic viral infections.
